Ndzhentiks
PRIVATE
STATUS
Grant
LATEST DEAL TYPE
$424K
LATEST DEAL AMOUNT
1
INVESTORS
Description
Developer of drugs for tuberculosis. The company develops drugs using a molecular-genetic platform for treating drug-resistant tuberculosis through semiconductor sequencing.
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare
Primary Office
- ul. Aviakonstruktora Mikoyana, 12
- Room 1
- Moscow, 125252
- Russia
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Ndzhentiks’s full profile, request a free trial.
Ndzhentiks Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Grant | 02-Dec-2014 | $424K | 00000 | Completed | Startup | |
| 1. Angel (individual) | 02-Dec-2014 | 00000 | 00000 | Completed | Startup |